The increased expression of EZH2 in ovarian tumors [36] could explain the reported relative resistance of OC cells to EMT [37, 38], or their preference towards MET, reverting to an epithelial phenotype immediately after dissemination from the primary tumor site. This evidence concerns the gene EZH2 and ovarian neoplasm.